When a respected analyst like Amy Raskin shares a positive outlook on a company, especially on a high-profile platform like CNBC, it can influence investor sentiment and lead to an increase in stock price. Given that this is a contrarian view, it suggests that the market may not have fully appreciated Illumina's potential, which could result in increased buying activity as investors reassess the company's prospects.